Antidiabetic treatment patterns and specialty care utilization among patients with type 2 diabetes and cardiovascular disease

• DOI: 10.1186/s12933-018-0699-7
• Publication Date: 2018-04-19T11:00:00Z
• Authors: Kevin M. Pantalone; Anita D. Misra-He...; Todd M. Hobbs; Xinge Ji; Sheldon X. Kong; Alex Milinovich; Wayne Weng; Janine Bauman; Rahul Ganguly; Bartolome Burguera; Michael W. Kattan; Robert S. Zimmerman
• Keywords: Angiology

To evaluate real-world patient characteristics, medication use, and health care utilization patterns in patients with type 2 diabetes established cardiovascular disease (CVD). Cross-sectional analysis of seen at Cleveland Clinic from 2005 to 2016, divided into two cohorts: with-CVD without-CVD. Patient demographics antidiabetic medications were recorded December 2016; department encounters included all visits 1/1/2016 12/31/2016. Comorbidity burden was assessed by the complications severity index (DCSI) score. Of 95,569 diabetes, 40,910 (42.8%) identified as having CVD. Patients CVD vs. those without older (median age 69.1 58.2 years), predominantly male (53.8% 42.6%), more likely have Medicare insurance (69.4% 35.3%). The cohort had a higher proportion DCSI score ≥ 3 than without-CVD (65.0% 10.3%). Utilization rates glucagon-like peptide-1 receptor agonists sodium–glucose co-transporter-2 inhibitors low both (4.1 2.5%) cohorts (5.4 4.1%), respectively. majority (75%) primary provider. During 1-year observation period, 81.9 62.0% not endocrinology or cardiology, These data indicated underutilization specialists reported confer CV benefit impact recently updated guidelines outcome trial results on management such remains be seen.